Biopharma & Life Sciences

Agilent Technologies Executive Compensation (FY25)

A · Executive and director compensation, fiscal 2022 to 2025
Chief executive, fiscal 2025
◇
Padraig McDonnell
Median of the other named officers
$3,658,593
5 officers, excluding the chief executive
Latest say-on-pay support
=
March 18, 2026
Chief executive pay ratio
◇
To the median employee
Velarion Member: every covered company in Biopharma & Life Sciences, with dashboards, peer screens and board-ready briefs. Three seats, one year.
Email me this page as a cited PDF — sent in 2 minutes
The same figures, the same citations, formatted to hand to a committee. Nothing is added that is not on this page.
Your address is used for this and nothing else. Unsubscribe in one click.

The paid brief on Agilent Technologies

Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
$1,500 for the Executive Compensation Report. Both reports for $2,400.
Data as of October 22, 2026Latest filing (8-K): March 20, 2026
13 filings cited on this page
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
Agilent Technologies brief$1,500Get the executive brief
Velarion Member, one year
494 figures on this page: 482 cited to the filing that reported them, 12 calculated from figures it prints. See the citations

More on Agilent Technologies

Five data products on this company. Each one is requested through the developer setup page.
What changed from fiscal 2024 to fiscal 2025
The figures that moved, and by how much. Analysis of these figures is part of the Velarion platform.
Chief executive total compensation — Padraig McDonnell: $9,046,505 → $12,827,236 (41.8% higher)
Say-on-pay support: 89.2% → 91.5% (2.3 points higher)
CEO pay ratio: 120:1 → 155:1 (29.2% higher)

Frequently asked questions

Answers drawn from the data on this page.
Who is Agilent Technologies' chief executive and what were they paid?
Padraig McDonnell was paid $12,827,236 in total compensation as President; Chief Executive Officer for fiscal 2025. McDonnell's total was 41.8% higher than the $9,046,505 reported for fiscal 2024.
What was Agilent Technologies' say-on-pay result?
The say-on-pay proposal drew 91.5% of votes cast including abstentions in favor at the meeting held March 18, 2026 for fiscal 2025.
Which companies are in Agilent Technologies' peer group?
The disclosed peer group includes Align Technology, Baxter Intl, Biogen, Boston Scientific and Catalent, among others. The additional disclosed peer group includes Align Technology, Biogen, Catalent, Charles River Labs and Cooper, among others.
What is Agilent Technologies' chief executive pay ratio?
The company reported a chief executive pay ratio of 155:1 for fiscal 2025, against median employee compensation of $82,873.

Executive compensation

Every element reported for each named executive officer, by fiscal year.
Fiscal 2022
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Michael McMullen
President and Chief Executive Officer
◇—◇◇◇—◇◇
Robert McMahon
Senior Vice President, Chief Financial Officer
◇—◇◇◇—◇◇
Henrik Ancher-Jensen
Senior Vice President, President Order Fulfillment and Supply Chain
◇—◇◇◇—◇◇
Sam Raha
Senior Vice President, President Diagnostics and Genomics Group
◇—◇◇◇—◇◇
Padraig McDonnell
Senior Vice President, President Agilent CrossLab
◇—◇◇◇—◇◇
Fiscal 2023
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Michael McMullen
President and Chief Executive Officer
◇—◇◇◇—◇◇
Robert McMahon
Senior Vice President, Chief Financial Officer
◇—◇◇◇—◇◇
Henrik Ancher-Jensen
Senior Vice President, President Order Fulfillment and Supply Chain
◇—◇◇◇—◇◇
Sam Raha
Senior Vice President, President Diagnostics and Genomics Group
◇—◇◇◇—◇◇
Padraig McDonnell
Senior Vice President, President Agilent CrossLab
◇—◇◇◇—◇◇
Fiscal 2024
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Michael R. McMullen
Former Chief Executive Officer
Departed during or after this year
◇—◇◇◇—◇◇
Padraig McDonnell
Chief Executive Officer
◇—◇◇◇—◇◇
Robert McMahon
Senior Vice President, Chief Financial Officer
◇—◇◇◇—◇◇
Henrik Ancher-Jensen
Senior Vice President, President Order Fulfillment and Supply Chain
◇—◇◇◇—◇◇
Dominique Grau
Senior Vice President, Chief Human Resources Officer
◇—◇◇◇◇◇◇†
Simon May
Senior Vice President, President Diagnostics and Genomics Group
◇◇◇◇◇—◇◇
Fiscal 2025
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Padraig McDonnell
President; Chief Executive Officer
◇—◇◇◇—◇◇
Robert McMahon
Former Senior Vice President; Former Chief Financial Officer
Departed during or after this year
◇—◇◇——◇◇
Simon May
Senior Vice President, Agilent President Life Sciences and Diagnostics Market Group
◇◇◇◇◇—◇◇
Bret DiMarco
Senior Vice President, Chief Legal Officer
◇—◇◇◇—◇◇
Angelica Riemann
Senior Vice President, Agilent President Agilent Cross-Lab Group
◇—◇◇◇—◇◇
Rodney Gonsalves
Vice President; Controller; Principal Accounting Officer; Interim Chief Financial Officer
Served on an interim basis
◇—◇◇◇—◇◇
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. A negative change in pension value is shown but, as the company reports it, not included in the total.

Equity awards granted

Individual awards as disclosed: type, date, unit counts at each level, and grant date value.
Fiscal 2025
OfficerAwardGrant dateThreshold unitsTarget unitsUnits grantedMaximum unitsExercise priceGrant date fair value
Angelica RiemannPSU◇◇◇—◇—◇
Angelica RiemannPSU◇◇◇—◇—◇
Angelica RiemannOPTION◇——◇—◇◇
Bret DiMarcoPSU◇◇◇—◇—◇
Bret DiMarcoOPTION◇——◇—◇◇
Bret DiMarcoPSU◇◇◇—◇—◇
Padraig McDonnellPSU◇◇◇—◇—◇
Padraig McDonnellOPTION◇——◇—◇◇
Padraig McDonnellPSU◇◇◇—◇—◇
Robert McMahonOPTION◇——◇—◇◇
Robert McMahonPSU◇◇◇—◇—◇
Robert McMahonPSU◇◇◇—◇—◇
Robert McMahonRSU◇——◇——◇
Rodney GonsalvesPSU◇◇◇—◇—◇
Rodney GonsalvesRSU◇——◇——◇
Rodney GonsalvesOPTION◇——◇—◇◇
Rodney GonsalvesPSU◇◇◇—◇—◇
Simon MayOPTION◇——◇—◇◇
Simon MayPSU◇◇◇—◇—◇
Simon MayPSU◇◇◇—◇—◇
Fiscal 2023, 2024 are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. Threshold, target and maximum apply only to performance awards and are never shown for time-based or option awards.

Outstanding awards

Awards still held at fiscal year end.
As disclosed at fiscal 2025 year end
OfficerAwardUnvested unitsMarket value of unvested unitsExercise priceExpires
Padraig McDonnellRSU◇◇——
PSU◇◇——
PSU◇◇——
PSU◇◇——
RSU◇◇——
PSU◇◇——
PSU◇◇——
PSU◇◇——
RSU◇◇——
PSU◇◇——
PSU◇◇——
PSU◇◇——
PSU◇◇——
RSU◇◇——
PSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
Option◇—◇11/15/2032
Option◇—◇3/1/2034
RSU◇◇——
Option◇—◇11/16/2031
Option◇—◇11/22/2033
Option◇—◇6/3/2034
Option◇—◇11/27/2034
Rodney GonsalvesRSU◇◇——
PSU◇◇——
PSU◇◇——
RSU◇◇——
RSU◇◇——
PSU◇◇——
RSU◇◇——
PSU◇◇——
PSU◇◇——
PSU◇◇——
PSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
Option◇—◇11/16/2031
Option◇—◇11/15/2032
Option◇—◇11/22/2033
Option◇—◇11/27/2034
Option◇—◇5/8/2034
Angelica RiemannRSU◇◇——
RSU◇◇——
RSU◇◇——
PSU◇◇——
PSU◇◇——
PSU◇◇——
RSU◇◇——
PSU◇◇——
PSU◇◇——
PSU◇◇——
PSU◇◇——
PSU◇◇——
PSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
Option◇—◇3/1/2034
Option◇—◇11/16/2031
Option◇—◇11/15/2032
Option◇—◇11/22/2033
Option◇—◇11/27/2034
Bret DiMarcoPSU◇◇——
RSU◇◇——
RSU◇◇——
PSU◇◇——
PSU◇◇——
PSU◇◇——
PSU◇◇——
RSU◇◇——
RSU◇=——
RSU◇◇——
Option◇—◇11/27/2034
Simon MayRSU◇◇——
PSU◇◇——
PSU◇◇——
PSU◇◇——
PSU◇◇——
PSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
Option◇—◇11/27/2034
Robert McMahonRSU◇=——
RSU◇◇——
RSU◇◇——
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Severance and change in control

The terms as written in the agreements.
Bret DiMarco
Senior Vice President, Chief Legal Officer · Terms as announced by the company · citing a 2026 filing
Severance multiple◇

Director compensation

What each non-employee director was paid.
Fiscal 2025
DirectorFees earned in cashStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Koh Boon Hwee
Board chair
◇◇———◇◇
Dow R. Wilson
◇◇————◇
George A. Scangos
◇◇————◇
Mikael Dolsten
◇◇————◇
Daniel K. Podolsky
◇◇————◇
Sue H. Rataj
◇◇————◇
Mala Anand
◇◇————◇
Otis W. Brawley
◇◇————◇
Heidi Kunz
◇◇————◇
Judy Gawlik Brown
◇◇———◇◇
Pascal Soriot
◇◇————◇
Padraig McDonnell served on the board in fiscal 2025 and received no compensation for board service. Executive directors are typically paid through their executive roles, shown above.
Earlier years are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Director fee schedule

The standing retainers and premiums the board pays, as published.
Board cash retainer◇
Board equity retainer◇
Total board retainer◇
Board chair premium◇
Audit committee chair◇
Audit committee member◇
Compensation committee chair◇
Equity is delivered as Stock.

Disclosed peer group

The companies this board named as its compensation comparison group. The list is disclosure; the comparison is analysis.
Fiscal 2025
  • Align Technology ALGN
  • Baxter Intl BAX
  • Biogen BIIB
  • Boston Scientific BSX
  • Catalent CTLT
  • Charles River Labs CRL
  • Cooper Companies COO
  • Danaher DHR
  • DaVita HealthCare DVA
  • DexCom DXCM
  • Edwards Lifesciences EW
  • Hologic HOLX
  • IDEXX Labs IDXX
  • Illumina ILMN
  • Incyte INCY
  • Intuitive Surgical ISRG
  • IQVIA IQV
  • Mettler-Toledo MTD
  • Moderna MRNA
  • Quest Diagnostics DGX
  • Regeneron Pharma REGN
  • ResMed RMD
  • Revvity RVTY
  • Solventum SOLV
  • Steris STE
  • Thermo Fisher TMO
  • Vertex Pharmaceuticals VRTX
  • Viatris VTRS
  • Waters WAT
  • Zimmer ZBH
  • Zoetis ZTS
Additional disclosed peer group
  • Align Technology ALGN
  • Biogen BIIB
  • Catalent CTLT
  • Charles River Labs CRL
  • Cooper COO
  • Danaher DHR
  • DaVita HealthCare DVA
  • DexCom DXCM
  • Hologic HOLX
  • IDEXX Labs IDXX
  • Illumina ILMN
  • Incyte INCY
  • Lab Corp of America LH
  • Mettler-Toledo MTD
  • Moderna MRNA
  • ResMed RMD
  • Revvity REVT
  • Solventum SOLV
  • Steris STE
  • Viatris VTRS
  • Waters WAT
  • Zimmer ZMH
  • Zoetis ZTS

Say-on-pay history

Shareholder support for the compensation program, by year.
YearMeetingSupportVotes forVotes againstAbstentions
2025March 18, 2026=◇◇◇
2024March 13, 2025=◇◇◇
2023March 14, 2024=◇◇◇
2022March 15, 2023=◇◇◇
2021March 16, 2022=◇◇◇
2020March 17, 2021=◇◇◇
2019April 17, 2020=◇◇◇
2018March 20, 2019=◇◇◇
2017March 21, 2018=◇◇◇
2016March 15, 2017=◇◇◇

Chief executive pay ratio

As calculated and reported by the company.
Ratio
◇
Median employee compensation
◇
Chief executive total compensation
◇

Velarion Pro: every company page, peer tools and exports, one seat

One seat, one person. It opens the whole platform: the peer tools, the written analysis and the exports, on every company we cover. Join the list and you will hear from us when it opens.
Your address is used for this and nothing else, and you can unsubscribe in one click. See the privacy policy.

Ask our research desk — $99, 24h, every figure cited to its filing.

Sample answer — “What is the CEO’s total compensation?”
- Padraig McDonnell (President; Chief Executive Officer), FY2025 total compensation $12,827,236 (base salary $1,141,345) [exec_comp, SEC accession 0001193125-26-040286, filed 2026-02-06]

Answered within 24 hours, every figure cited to its SEC filing. If our database cannot answer your question, you are refunded automatically.

Tell me when Agilent Technologies files
You get a note when this company’s compensation data changes.
Your address is used for this and nothing else. Unsubscribe in one click.

What this page does not include

Everything above is a fact Agilent Technologies disclosed, and it is free. Everything below is our analysis of those facts, and it is not.
Peer benchmarking
Where Agilent Technologies sits against its disclosed peers — percentile position by role and by pay element, and the ranking behind it. The disclosed peer group is free; comparisons across it are part of the Velarion platform.
Executive Compensation Report — $1,500
Written compensation analysis
A read of the pay program as designed and as paid: incentive structure, goal rigor, the alignment between the committee's stated philosophy and what the numbers show.
Executive Compensation Report — $1,500
Board and governance analysis
Committee composition, independence, director pay positioning, and the governance provisions read together rather than listed.
Board Governance Report — $499
Realizable pay
What the awards above are actually worth today against what they were valued at on grant, and what the gap says about the pay-for-performance link.
Velarion Intelligence
Adviser switching and vote outcomes
Two datasets covering compensation-adviser changes and what followed a contested vote. Both are part of the Velarion platform.
Inquire about access
Multiple companies at once
Cross-company views, cohort screens, and data export across the industries we cover. This page is one company; the platform is all of them.
Velarion Intelligence
Join the list for Peer Group Review
Whether Agilent Technologies' disclosed peer group is defensible, who names Agilent Technologies back in their own benchmarking group, and how pay tracks performance across it. This is the analysis a compensation consultant delivers on the group above. We will email you when it opens.
Your address is used for this and nothing else. Unsubscribe in one click.

Citations

Every figure on this page is cited to the document that reported it. Select any figure to see its citation.
494 figures on this page: 482 cited to the filing that reported them, 12 calculated from figures it prints.
482 cited to the filing
12 calculated from the filing

Documents cited

  1. 0001193125-26-117614
    Item 5.07 Submission of Matters to a Vote of Security Holders
  2. 0001193125-26-040286
    CEO Pay Ratio · Compensation Discussion and Analysis · Grants of Plan-Based Awards · Non-Employee Director Compensation for Fiscal Year 2025 · and 2 more sections
  3. 0000950170-25-040344
    Item 5.07 Submission of Matters to a Vote of Security Holders
  4. 0000950170-25-011439
    Summary Compensation Table
  5. 0000950170-24-032163
    Item 5.07 Submission of Matters to a Vote of Security Holders
  6. 0000950170-24-010096
    Summary Compensation Table
  7. 0000950170-23-008638
    Item 5.07 Submission of Matters to a Vote of Security Holders
  8. 0001564590-22-010863
    Item 5.07 Submission of Matters to a Vote of Security Holders
  9. 0001564590-21-014146
    Item 5.07 Submission of Matters to a Vote of Security Holders
  10. 0001564590-20-017459
    Item 5.07 Submission of Matters to a Vote of Security Holders
  11. 0001564590-19-009011
    Item 5.07 Submission of Matters to a Vote of Security Holders
  12. 0001564590-18-006570
    Item 5.07 Submission of Matters to a Vote of Security Holders
  13. 0001564590-17-004619
    Item 5.07 Submission of Matters to a Vote of Security Holders
Cite this data
This page is free to cite. Attribution we ask for:
Velarion, “Agilent Technologies executive compensation, FY2022–FY2025.” https://intel.velarion.ai/comp/A (accessed 2026).
Short form: data: Velarion

The paid brief for Agilent Technologies

Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
$1,500 for the Executive Compensation Report. Both reports for $2,400.
13 filings cited on this page
Method: intel.velarion.ai/methodology
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
Embed this data
A small, cited view of this data for your own page or newsletter. Every embed carries a visible link back here, so the attribution travels with it.
The headline figures, each with its citation.
Connect an AI assistant
Ask your own assistant about Agilent Technologies and roughly 3,000 other US public companies, and get back the same figures on this page with the same citations. Free read access, no account. Add this to your assistant's connector settings.

Biopharma & Life Sciences rankings

Peers Agilent Technologies discloses

The companies named in A's own disclosed peer group.

Terms on this page

Free to read and cite. Redistribution or bulk use of the dataset requires a data license. Talk to us about the data license.

Cite this data
APA
Velarion Company Intelligence. (2026). Velarion database: executive and board compensation data (Version 2026Q3) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.22283854
BibTeX
@misc{velarionData2026,
  author = {{Velarion Company Intelligence}},
  title = {Velarion database: executive and board compensation data},
  year = {2026},
  version = {2026Q3},
  doi = {10.5281/zenodo.22283854},
  publisher = {Zenodo},
  url = {https://doi.org/10.5281/zenodo.22283854}
}
For informational purposes only. Not investment, legal, or compensation advice.  All companies · The Pay Desk · Methodology · Terms · Privacy